Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial.
Auteur(s) : Hulot, JS ; Salem, JE ; Redheuil, A ; Collet, JP ; Varnous, S ; Jourdain, P & al Revue : Eur J Heart Fail
